New Discovery: LRRK2 Therapies Could Benefit Wider Population | FoxFlash July 2018

Wider Population May Benefit from LRRK2 Therapies in Development

New findings from a Foundation-funded study suggest that the LRRK2 protein may have a role in Parkinson's disease among people who don't carry the LRRK2mutation. This means that LRRK2-targeted treatments currently in development also could be useful for people without the mutation.

Discover More > Urinary Problems in Parkinson's Disease Hear expert discussion and ask your questions in our Third Thursdays Webinar series.  August 16, 2018 at 12 p.m. ET